Rhynchophylline relieves nonalcoholic fatty liver disease by activating lipase and increasing energy metabolism
International Immunopharmacology · 2023
DOI: 10.1016/j.intimp.2023.109948 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2023. Verfasst von Kang Liu und 12 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for Conservation and Utilization of Subtropical Agro-bioresources, College of Animal Science and Technology, Guangxi University,…. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Natural Science Foundation of Guangxi Province, Science Fund for Distinguished Young Scholars of Guangxi Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Hepatic fat metabolism may be altered in the context of overnutrition and obesity, often resulting in the accumulation of triglycerides in hepatocytes and leading to nonalcoholic fatty liver disease (NAFLD). Natural plant alkaloids have demonstrated great potential for the prevention and treatment of NAFLD. However, the role of rhynchophylline (RHY) in lipid metabolism is not clear. We explored the role of RHY in lipid metabolism in cells treated with oleic and palmitic acids to mimic high-fat diet (HFD) conditions. RHY attenuated oleic and palmitic acid-induced increases in triglyceride accumulation in HepG2, AML12, and LMH cells. RHY also increased energy metabolism and reduced oxidative stress. We further investigated the effect of RHY on hepatic lipid metabolism in mice fed an HFD including 40 mg/kg RHY. RHY alleviated hepatic steatosis, reduced fat deposition, promoted energy metabolism, and improved glucose metabolism. We investigated the mechanism responsible for this activity by docking with key proteins of lipid metabolism disorders using Discovery Studio software, which showed that RHY interacted well with lipases. Finally, we found that adding RHY promoted lipase activity and lipolysis. In conclusion, RHY ameliorated HFD-induced NAFLD and its complications by increasing lipase activity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory for Conservation and Utilization of Subtropical Agro-bioresources, College of Animal Science and Technology, Guangxi University, Nanning 530004, PR China.
- State Key Laboratory for Conservation and Utilization of Subtropical Agro-bioresources, College of Animal Science and Technology, Guangxi University, Nanning 530004, PR China. Electronic address: liyixing39@gxu.edu.cn.
Förderung
- Natural Science Foundation of Guangxi Province
- Science Fund for Distinguished Young Scholars of Guangxi Province
- National Natural Science Foundation of China
Zitieren
APA
Liu, K., Liu, S., Wu, C., Wang, Y., Zhang, Y., Yu, J., Liu, S., Li, X., Qi, X., Su, S., Qi, X., Zhou, L., & Li, Y. (2023). Rhynchophylline relieves nonalcoholic fatty liver disease by activating lipase and increasing energy metabolism. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2023.109948
Vancouver
Liu K, Liu S, Wu C, Wang Y, Zhang Y, Yu J, et al. Rhynchophylline relieves nonalcoholic fatty liver disease by activating lipase and increasing energy metabolism. International Immunopharmacology. 2023. doi:10.1016/j.intimp.2023.109948
BibTeX
@article{Liu2023,
author = {Liu, Kang and Liu, Songsong and Wu, Chou and Wang, Yuwei and Zhang, Yurou and Yu, Jingsu and Liu, Siqi and Li, Xiangling and Qi, Xinyu and Su, Songtao and Qi, Xinyi and Zhou, Lei and Li, Yixing},
title = {Rhynchophylline relieves nonalcoholic fatty liver disease by activating lipase and increasing energy metabolism},
journal = {International Immunopharmacology},
year = {2023},
doi = {10.1016/j.intimp.2023.109948}
}
EUVIMED